| 50090-4727-4 |
50090-4727 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
100 TABLET, FILM COATED in 1 BOTTLE (50090-4727-4) |
| 50090-4727-6 |
50090-4727 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
7 TABLET, FILM COATED in 1 BOTTLE (50090-4727-6) |
| 50090-4727-7 |
50090-4727 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
14 TABLET, FILM COATED in 1 BOTTLE (50090-4727-7) |
| 50090-4727-8 |
50090-4727 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
21 TABLET, FILM COATED in 1 BOTTLE (50090-4727-8) |
| 50090-4727-9 |
50090-4727 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
10 TABLET, FILM COATED in 1 BOTTLE (50090-4727-9) |
| 50090-4729-0 |
50090-4729 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
3 TABLET, FILM COATED in 1 BOTTLE (50090-4729-0) |
| 50090-4729-1 |
50090-4729 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
12 TABLET, FILM COATED in 1 BOTTLE (50090-4729-1) |
| 50090-4729-4 |
50090-4729 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
42 TABLET, FILM COATED in 1 BOTTLE (50090-4729-4) |
| 50090-4729-8 |
50090-4729 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
6 TABLET, FILM COATED in 1 BOTTLE (50090-4729-8) |
| 50090-4730-0 |
50090-4730 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20191118 |
N/A |
ANDA |
ANDA208170 |
A-S Medication Solutions |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
90 TABLET, FILM COATED in 1 BOTTLE (50090-4730-0) |
| 67296-2084-1 |
67296-2084 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20170531 |
N/A |
ANDA |
ANDA208170 |
Redpharm Drug |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
15 TABLET, FILM COATED in 1 BOTTLE (67296-2084-1) |
| 67296-2084-2 |
67296-2084 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20170531 |
N/A |
ANDA |
ANDA208170 |
Redpharm Drug |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
10 TABLET, FILM COATED in 1 BOTTLE (67296-2084-2) |
| 67296-2084-3 |
67296-2084 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20170531 |
N/A |
ANDA |
ANDA208170 |
Redpharm Drug |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE (67296-2084-3) |
| 67296-2084-4 |
67296-2084 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20170531 |
N/A |
ANDA |
ANDA208170 |
Redpharm Drug |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
21 TABLET, FILM COATED in 1 BOTTLE (67296-2084-4) |
| 51655-427-26 |
51655-427 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20210401 |
N/A |
ANDA |
ANDA208170 |
Northwind Health Company, LLC |
CYCLOBENZAPRINE HYDROCHLORIDE |
5 mg/1 |
90 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-427-26) |
| 51655-427-52 |
51655-427 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20220413 |
N/A |
ANDA |
ANDA208170 |
Northwind Health Company, LLC |
CYCLOBENZAPRINE HYDROCHLORIDE |
5 mg/1 |
30 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-427-52) |
| 51655-427-53 |
51655-427 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20200901 |
N/A |
ANDA |
ANDA208170 |
Northwind Health Company, LLC |
CYCLOBENZAPRINE HYDROCHLORIDE |
5 mg/1 |
10 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-427-53) |
| 68071-3805-1 |
68071-3805 |
HUMAN PRESCRIPTION DRUG |
Cyclobenzaprine Hydrochloride |
Cyclobenzaprine Hydrochloride |
TABLET, FILM COATED |
ORAL |
20250304 |
N/A |
ANDA |
ANDA208170 |
NuCare Pharmaceuticals, Inc. |
CYCLOBENZAPRINE HYDROCHLORIDE |
7.5 mg/1 |
15 TABLET, FILM COATED in 1 BOTTLE (68071-3805-1) |
| 68071-3805-7 |
68071-3805 |
HUMAN PRESCRIPTION DRUG |
Cyclobenzaprine Hydrochloride |
Cyclobenzaprine Hydrochloride |
TABLET, FILM COATED |
ORAL |
20250304 |
N/A |
ANDA |
ANDA208170 |
NuCare Pharmaceuticals, Inc. |
CYCLOBENZAPRINE HYDROCHLORIDE |
7.5 mg/1 |
21 TABLET, FILM COATED in 1 BOTTLE (68071-3805-7) |
| 51655-539-20 |
51655-539 |
HUMAN PRESCRIPTION DRUG |
CYCLOBENZAPRINE HYDROCHLORIDE |
cyclobenzaprine hydrochloride |
TABLET, FILM COATED |
ORAL |
20210114 |
N/A |
ANDA |
ANDA208170 |
Northwind Health Company, LLC |
CYCLOBENZAPRINE HYDROCHLORIDE |
10 mg/1 |
20 TABLET, FILM COATED in 1 BOTTLE, PLASTIC (51655-539-20) |